Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury

Author:

Anand Praveen,Shenoy Ravikiran,Palmer Joanne E.,Baines Amanda J.,Lai Robert Y.K.,Robertson Jonathan,Bird Nick,Ostenfeld Thor,Chizh Boris A.

Publisher

Wiley

Subject

Anesthesiology and Pain Medicine

Reference45 articles.

1. Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling;Alford;J Biol Chem,2007

2. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons;Anand;Neurosci Lett,2008

3. The potential role of nerve growth factor (NGF) in painful neuromas and the mechanism of pain relief by their relocation to muscle;Atherton;J Hand Surg Br,2006

4. Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?;Attal;Pain,2008

5. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function;Badger;J Pharmacol Exp Ther,1996

Cited by 136 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3